Cancer clinical trials in the region Occitanie
132 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05882734
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
EGFR
ALK
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 2 more...)
Merck KGaA
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Lymphoma
#NCT04509700
B cell lymphoma
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Incyte Corporation
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Mantel cell lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Follicular lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lung cancer
#NCT05925530
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Systemic Treatment-Naive
EGFR
ALK
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Grenoble (La Tronche), Hôpital de la Timone AP-HM (Marseille), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier) (and 1 more...)
AstraZeneca
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Hôpital Larrey (Toulouse ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Tenon AP-HP (Paris ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre François Baclesse (Caen ) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05325866
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen
Phase 2
Breast cancer
#NCT05325866
HER2 Negative
HR Negative
Locally Advanced
Metastatic
FGFR
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie